[go: up one dir, main page]

SI2573568T1 - Razlikovalni test - Google Patents

Razlikovalni test

Info

Publication number
SI2573568T1
SI2573568T1 SI200831417T SI200831417T SI2573568T1 SI 2573568 T1 SI2573568 T1 SI 2573568T1 SI 200831417 T SI200831417 T SI 200831417T SI 200831417 T SI200831417 T SI 200831417T SI 2573568 T1 SI2573568 T1 SI 2573568T1
Authority
SI
Slovenia
Prior art keywords
distinguishing assay
distinguishing
assay
Prior art date
Application number
SI200831417T
Other languages
English (en)
Inventor
Kay-Gunnar Stubenrauch
Markus Zadak
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of SI2573568T1 publication Critical patent/SI2573568T1/sl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SI200831417T 2007-12-15 2008-12-12 Razlikovalni test SI2573568T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07024353 2007-12-15
EP08002450 2008-02-11
EP12196714.5A EP2573568B1 (en) 2007-12-15 2008-12-12 Distinguishing assay

Publications (1)

Publication Number Publication Date
SI2573568T1 true SI2573568T1 (sl) 2015-05-29

Family

ID=40339911

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200831417T SI2573568T1 (sl) 2007-12-15 2008-12-12 Razlikovalni test

Country Status (15)

Country Link
US (2) US8227195B2 (sl)
EP (2) EP2223118B1 (sl)
JP (2) JP5221673B2 (sl)
KR (1) KR101187627B1 (sl)
CN (2) CN103399145B (sl)
AU (1) AU2008337904B2 (sl)
BR (1) BRPI0821267A2 (sl)
CA (1) CA2709127C (sl)
DK (1) DK2573568T3 (sl)
ES (2) ES2407603T3 (sl)
IL (2) IL205206A (sl)
MX (1) MX2010005891A (sl)
PL (1) PL2573568T3 (sl)
SI (1) SI2573568T1 (sl)
WO (1) WO2009077127A1 (sl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU736282B2 (en) 1997-03-21 2001-07-26 Chugai Seiyaku Kabushiki Kaisha A preventive or therapeutic agent for sensitized T cell- mediated diseases comprising IL-6 antagonist as an active ingredient
UA80091C2 (en) 2001-04-02 2007-08-27 Chugai Pharmaceutical Co Ltd Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist
WO2003068259A1 (fr) * 2002-02-14 2003-08-21 Chugai Seiyaku Kabushiki Kaisha Produits pharmaceutiques en solution contenant des anticorps
GB2401040A (en) 2003-04-28 2004-11-03 Chugai Pharmaceutical Co Ltd Method for treating interleukin-6 related diseases
JPWO2005090405A1 (ja) 2004-03-24 2008-04-17 中外製薬株式会社 インターロイキン−6受容体に対するヒト型化抗体のサブタイプ
EP1996943B1 (en) * 2006-03-09 2014-06-25 F.Hoffmann-La Roche Ag Anti-drug antibody assay
PE20091174A1 (es) 2007-12-27 2009-08-03 Chugai Pharmaceutical Co Ltd Formulacion liquida con contenido de alta concentracion de anticuerpo
HUE033758T2 (en) 2009-10-26 2017-12-28 Hoffmann La Roche A method for producing glycosylated immunoglobulin
EP2354792A1 (en) * 2010-02-08 2011-08-10 Biomonitor A/S Method for detecting anti-drug antibodies
CN102884433A (zh) * 2010-04-29 2013-01-16 塞拉蒂亚戈公司 用于检测抗体的方法
EP4029881A1 (en) 2010-11-08 2022-07-20 F. Hoffmann-La Roche AG Subcutaneously administered anti-il-6 receptor antibody
BR112015032960B1 (pt) * 2013-07-04 2021-01-05 F. Hoffmann-La Roche Ag imunoensaio suprimido por interferência para detectar anticorpos anti-fármaco em amostras de soro
ES2699581T3 (es) * 2013-12-20 2019-02-11 Phadia Ab Análisis de anticuerpos
JP6739428B2 (ja) * 2014-11-05 2020-08-12 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft エフェクター機能抑制型ヒトまたはヒト化薬物抗体に対する抗薬物抗体の決定方法
WO2017147169A1 (en) 2016-02-22 2017-08-31 Ohio State Innovation Foundation Chemoprevention using controlled-release formulations of anti-interleukin 6 agents, synthetic vitamin a analogues or metabolites, and estradiol metabolites
US11033496B2 (en) 2017-03-17 2021-06-15 The Regents Of The University Of Michigan Nanoparticles for delivery of chemopreventive agents
CN114910635B (zh) * 2017-10-26 2025-05-02 科美诊断技术股份有限公司 一种无基质效应的均相免疫检测试剂盒及其应用
US20220177978A1 (en) 2019-04-02 2022-06-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods of predicting and preventing cancer in patients having premalignant lesions
KR102583329B1 (ko) * 2020-11-12 2023-09-27 바디텍메드(주) 자성 입자 기반 약물 또는 약물 항체 검출 방법
JP7062803B1 (ja) 2021-03-31 2022-05-06 積水メディカル株式会社 抗薬物抗体測定方法
WO2025224166A1 (en) * 2024-04-23 2025-10-30 F. Hoffmann-La Roche Ag Anti-drug antibody assays

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219730A (en) 1982-09-28 1993-06-15 New York University Idiotype-anti-idiotype immunoassay
US4828981A (en) 1983-08-24 1989-05-09 Synbiotics Corporation Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents
EP0170302A1 (fr) 1984-06-27 1986-02-05 l'Association internationale à but scientifique, dite: Institut international de pathologie cellulaire et moléculaire Procédé de dosage immunologique d'une substance dans un échantillon liquide au moyen d'anticorps anti-idiotypiques
US5238808A (en) 1984-10-31 1993-08-24 Igen, Inc. Luminescent metal chelate labels and means for detection
EP0243471A4 (en) 1985-10-22 1989-07-11 Cooper Lipotech Inc SOLID PHASE LIPOSOME IMMUNOANALYSIS SYSTEM.
US5202238A (en) 1987-10-27 1993-04-13 Oncogen Production of chimeric antibodies by homologous recombination
US5204244A (en) 1987-10-27 1993-04-20 Oncogen Production of chimeric antibodies by homologous recombination
US5068088A (en) 1988-11-03 1991-11-26 Igen, Inc. Method and apparatus for conducting electrochemiluminescent measurements
KR0143993B1 (ko) 1988-11-03 1998-07-15 리차아드 제이 매씨이 전기화학 발광성 분석
WO1990006515A1 (en) 1988-12-09 1990-06-14 Centocor, Inc. Anti-idiotopic immunometric assay
IL100866A (en) 1991-02-06 1995-10-31 Igen Inc Method and apparatus for magnetic microparticulate based luminescence assay including plurality of magnets
US5614191A (en) 1995-03-15 1997-03-25 The United States Of America As Represented By The Department Of Health And Human Services IL-13 receptor specific chimeric proteins and uses thereof
US6015681A (en) * 1995-07-28 2000-01-18 The United States Of America As Represented By The Secretary Of The Navy Rapid immunoassay for cariogenic bacteria
EP0907730B1 (en) 1995-10-23 2009-10-07 Zenyth Operations Pty Ltd Haemopoietin receptor and genetic sequences encoding same
DE19649390A1 (de) * 1996-11-29 1998-06-04 Boehringer Mannheim Gmbh Antigenspezifischer IgG-Nachweis
WO1998033523A1 (en) 1997-01-31 1998-08-06 Biovation Limited Vaccination methods and molecules
ES2258817T3 (es) 1997-05-21 2006-09-01 Biovation Limited Metodo para la produccion de proteinas no inmunogenas.
ATE352559T1 (de) 1998-12-08 2007-02-15 Biovation Ltd Verfahren zur verminderung der immunogenität von proteinen
WO2003080675A2 (en) 2002-03-22 2003-10-02 Amrad Operations Pty Ltd MONOCLONAL ANTIBODY AGAINST INTERLEUKIN-13 RECEPTOR ALPHA 1 (IL-13Rα1)
US7211396B2 (en) * 2002-04-18 2007-05-01 Antibodyshop A/S Antibody pairs and kits for immunochemical determination of mannan-binding lectin
EP1634606A1 (en) 2003-03-31 2006-03-15 Kyowa Hakko Kogyo Co., Ltd. Drug for airway administration
JP4473257B2 (ja) 2003-04-02 2010-06-02 エフ.ホフマン−ラ ロシュ アーゲー インスリン様成長因子i受容体に対する抗体及びその使用
AR046071A1 (es) 2003-07-10 2005-11-23 Hoffmann La Roche Anticuerpos contra el receptor i del factor de crecimiento de tipo insulinico y los usos de los mismos
US20050130246A1 (en) 2003-10-27 2005-06-16 Hossein Salimi-Moosavi Detecting human anti-therapeutic antibodies
TWI306862B (en) 2005-01-03 2009-03-01 Hoffmann La Roche Antibodies against il-13 receptor alpha 1 and uses thereof
DK2645106T4 (da) 2005-04-04 2024-12-02 Biogen Ma Inc Fremgangsmåder til evaluering af et immunrespons på et terapeutisk middel
EP1996943B1 (en) 2006-03-09 2014-06-25 F.Hoffmann-La Roche Ag Anti-drug antibody assay
CN101074958A (zh) * 2006-05-17 2007-11-21 上海森雄科技实业有限公司 一种层粘连蛋白诊断试剂盒

Also Published As

Publication number Publication date
CA2709127C (en) 2013-11-12
US20100304400A1 (en) 2010-12-02
AU2008337904B2 (en) 2014-02-13
US20120219974A1 (en) 2012-08-30
EP2573568A1 (en) 2013-03-27
JP5782644B2 (ja) 2015-09-24
KR20100077056A (ko) 2010-07-06
US8227195B2 (en) 2012-07-24
BRPI0821267A2 (pt) 2015-06-16
CN103399145A (zh) 2013-11-20
IL205206A (en) 2014-04-30
EP2223118A1 (en) 2010-09-01
IL205206A0 (en) 2010-12-30
PL2573568T3 (pl) 2015-05-29
ES2532483T3 (es) 2015-03-27
ES2407603T3 (es) 2013-06-13
WO2009077127A1 (en) 2009-06-25
JP5221673B2 (ja) 2013-06-26
KR101187627B1 (ko) 2012-10-09
IL220024A (en) 2014-04-30
DK2573568T3 (en) 2015-02-09
HK1189937A1 (en) 2014-06-20
IL220024A0 (en) 2012-06-28
US8530176B2 (en) 2013-09-10
CN101896820A (zh) 2010-11-24
CA2709127A1 (en) 2009-06-25
CN103399145B (zh) 2015-06-24
MX2010005891A (es) 2010-06-09
EP2223118B1 (en) 2013-02-27
JP2011506943A (ja) 2011-03-03
EP2573568B1 (en) 2015-01-14
AU2008337904A1 (en) 2009-06-25
JP2012112972A (ja) 2012-06-14

Similar Documents

Publication Publication Date Title
IL220024A0 (en) Distinguishing assay
GB0717043D0 (en) Assay device
GB201006435D0 (en) Assay device
GB0713930D0 (en) Novel assay methods
GB0706906D0 (en) Assay device
GB0811567D0 (en) Assay
GB0809262D0 (en) Assay
GB0807534D0 (en) Assay
GB0803850D0 (en) Assay
GB0811858D0 (en) Assay
GB0718606D0 (en) Multiparameter assay
GB0814591D0 (en) Assay
GB0822260D0 (en) Assay
GB0608446D0 (en) Assay
GB0600031D0 (en) Assay
GB0822010D0 (en) Assay
GB0821624D0 (en) Assay
GB0615813D0 (en) Assay
GB0607462D0 (en) Assay
GB0623892D0 (en) Assay
GB0722912D0 (en) Assay
GB0711955D0 (en) Assay
GB0715386D0 (en) Assay
GB0721944D0 (en) Assay
GB0719757D0 (en) Assay